Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-09

Clinical Trial Update: The Effect of Resistance Training on Proprotein Subtilisin Convertase Kexin 9 Level After Coronary Bypass Surgery [NA]

View source ↗

Summary

Clinical trial assessing how resistance training after coronary bypass surgery affects levels of Proprotein Subtilisin Kexin 9 (PCSK9).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Cardiovascular Center Harapan Kita Hospital Indonesia | Conditions: Coronary Artery Disease | NA | Status: COMPLETED | Results posted: 2019-12-09